methyl 4-mercaptobutyrimidate has been researched along with 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione in 1 studies
Studies (methyl 4-mercaptobutyrimidate) | Trials (methyl 4-mercaptobutyrimidate) | Recent Studies (post-2010) (methyl 4-mercaptobutyrimidate) | Studies (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) | Trials (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) | Recent Studies (post-2010) (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) |
---|---|---|---|---|---|
91 | 0 | 11 | 116 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beery, R; Bella, R; Geier, A; Haimsohn, M; Lunenfeld, B | 1 |
1 other study(ies) available for methyl 4-mercaptobutyrimidate and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
Article | Year |
---|---|
Differences in the association of the progesterone receptor ligated by antiprogestin RU38486 or progestin ORG 2058 to chromatin components.
Topics: Cell Line; Centrifugation, Density Gradient; Chromatin; Chromatography, Gel; Cross-Linking Reagents; Estrenes; Imidoesters; Micrococcal Nuclease; Mifepristone; Molecular Weight; Pregnenediones; Progesterone Congeners; Progestins; Receptors, Progesterone | 1987 |